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Theepidermal growthfactor receptor (EGFR)regulates theproliferationofkeratinocytes throughmultiplemechanisms thatdiﬀer
dependingonthelocalizationofthecellwithintheskin.Ultraviolet(UV)irradiation,themainetiologicfactor inthedevelopment
of skin cancer, also activates the receptor. In this review, we discuss how the UV-induced activation of EGFR regulates the response
oftheskintoUV.UV-inducedEGFRactivationincreaseskeratinocyteproliferation,suppressesapoptosis,andaugmentsandaccel-
erates epidermal hyperplasia in response to UV. Pharmacological inhibition of the UV-induced activation of EGFR in a genetically
initiated mouse skin tumorigenesis model suppresses tumorigenesis and the activation of mitogen-activated protein (MAP) ki-
nases and phosphatidyl inositol-3-kinase (PI3K)/AKT signaling pathways. EGFR has pleiotropic, complex, and cell-type-speciﬁc
functions in cutaneous keratinocytes; suggesting that the receptor is an appropriate target for the development of molecularly
targeted therapies for skin cancer and other pathologies.
Copyright © 2007 T. B. El-Abaseri and L. A. Hansen. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
Ultraviolet (UV) irradiation is the main etiological factor for
nonmelanoma skin cancer. UV has a wide variety of eﬀects
on the skin that contribute to the induction of skin cancer.
Our laboratory has for the last several years focused on the
role of the epidermal growth factor receptor (EGFR) in UV-
induced skin cancer.
EGFR is the prototypic member and the ﬁrst receptor
identiﬁed of the ErbB family of receptor tyrosine kinases
(RTKs). The ErbB receptor family includes EGFR as well as
three other receptors, ErbB2, ErbB3, and ErbB4. EGFR is a
single transmembrane glycoprotein of approximately 170kd
that was discovered in the mid-1970s as a binding site for
EGF(epidermalgrowthfactor).EGFisnowknowntobepart
of a large family of ligands for ErbB receptors. These growth
factors are of three types: those that bind to EGFR including
EGF,amphiregulin,andtransforminggrowthfactor-α(TGF-
α); those that bind to both EGFR and ErbB4 including be-
tacellulin, epiregulin, and heparin-binding EGF-like growth
factor,andthosethatbindtoerbB3anderbB4includingNeu
diﬀerentiation factors (heregulins) [1].
In na¨ ıve skin, EGFR stimulates proliferation, regulates
diﬀerentiation, and promotes cell survival [2–4]. Upon
trauma to the skin, the receptor increases cell adhesion and
the migration of keratinocytes during wound reepithelial-
ization [5]. In addition, the eﬀects of EGFR activation de-
pend on the localization of the cell within the skin [4].
EGFR’s localization in basal and suprabasal keratinocytes of
the epidermis and in the outer root sheath of the hair fol-
licle allows its wide diversity of action within the skin and
the potential for multiple roles during skin carcinogene-
sis.
Increased activation of EGFR family members has been
implicated in the development of a variety of human carci-
noma (reviewed in [6, 7]). Studies using transgenic mouse
models also provide evidence of the importance of EGFR
in tumorigenesis. Mice overexpressing cutaneous TGF-α ex-
hibit epidermal hyperplasia, hyperkeratosis, and increased
sensitivity to the chemical induction of skin tumors [8–10].
v-rasHa-initiated Egfr null skin grafts develop smaller tumors
when compared to wild-type control grafts as a result of the
premature migration of S-phase cells into the suprabasal dif-
ferentiating compartment [11, 12].2 Journal of Biomedicine and Biotechnology
Moreover, the development of spontaneous papillomas
intransgenicmiceexpressingadominantformofSonofSev-
enless (SOS-F), a guanine nucleotide exchange factor associ-
ated with Grb2 adaptor protein that transmits signals from
EGFR to ras, is reduced in mice bred onto an Egfr null back-
ground [13, 14]. Pharmacological inhibition of EGFR using
speciﬁc kinase inhibitors also results in decreased tumor vol-
ume in athymic nude mice grafted with EGFR overexpress-
ing cell lines [15]. Because EGFR is highly expressed in many
human tumors, two robust anti-EGFR strategies have been
used in clinical trials. These studies target EGFR using either
small-molecule tyrosine kinase inhibitors or monoclonal an-
tibodies and have been approved for the treatment of non-
small cell lung carcinoma, head and neck cancers, and col-
orectal cancer [7, 16].
From these data and our experiences in characterizing
the phenotype of Egfr null mice, we hypothesized that UV-
induced EGFR activation stimulates keratinocyte prolifera-
tion following UV irradiation. We further hypothesized that
the repeated activation of EGFR upon exposure of the skin
to UV contributes to the development of skin cancer. The
present review will describe the results of our research inves-
tigating the role of EGFR in the response of the skin to UV.
2. UV IRRADIATION ACTIVATES EGFR
UV irradiation rapidly activates EGFR and a number of
other cell surface receptors through reactive oxygen species-
mediated inactivation of the cytoplasmic protein tyrosine
phosphatases that maintain low basal levels of phosphory-
lated EGFR [17–21]. Increased EGFR activation is observed
withinminutesafterUVirradiationofculturedkeratinocytes
or skin [22, 23]. This initial pulse of receptor activation sub-
sides within an hour after UV irradiation, while the induc-
tion of EGFR ligands at later time points produces a sec-
ond later wave of receptor activation as well [17]. The phos-
phorylation of EGFR family members Erbb2 and Erbb3,
indicative of receptor activation, similarly increases follow-
ing UV irradiation of cultured keratinocytes or skin [24].
UV-activated EGFR in turn activates a number of signaling
cascades, including phosphatidyl inositol-3-kinase (PI3K),
leading to AKT activation and a suppression of apoptosis
[25, 26]. EGFR is also at least partly responsible for the acti-
vation of extracellular regulated kinases (ERKs), p38 kinase,
and c-Jun NH2-terminal kinase (JNK) following UV expo-
sure [22, 23, 27], all of which are known regulators of cell
division. Accordingly, we examined the importance of EGFR
in the regulation of proliferation following UV irradiation.
3. EGFR INCREASES CELL CYCLE PROGRESSION
THROUGH MULTIPLE MECHANISMS
Genetic ablation of Egfr signiﬁcantly reduces proliferation
in the interfollicular epidermis of the skin [3]. Because of
EGFR’s activation following UV exposure, we hypothesized
that EGFR-dependent signaling stimulates keratinocyte pro-
liferation following UV irradiation. To test this hypothesis,
genetic ablation of EGFR or an EGFR inhibitor was used
in both in vitro and in vivo model systems. Proliferation
is decreased in Egfr null epidermis and in EGFR inhibitor-
treated epidermis [2, 4, 22, 23]. Cultured keratinocytes with
abrogated EGFR function arrest in multiple cell cycle phases,
depending on the manipulation of the culture conditions.
Growth factor stimulation reveals a G1 p h a s ec e l lc y c l ea r r e s t
due to loss of EGFR’s activation of ERK1/2 and JNK path-
ways (unpublished observations and [15]). Without exoge-
nous addition of growth factor, ablation of EGFR causes a
G2/M arrest (unpublished observations). Further investiga-
tion is required to explain the mechanisms of its regulation
of the G2/M cell cycle checkpoint. However, our data sug-
gest that the cellular environment determines which EGFR-
dependent signaling pathways will be dominant.
The in vitro cell cycle data are consistent with our anal-
ysis of the role of EGFR in vivo. The role of physiological
levels of EGFR in keratinocytes depends quite clearly on the
cell’s localization within the skin. EGFR is necessary for the
normal organization and diﬀerentiation of the follicular ep-
ithelium but not of the interfollicular epidermis [2, 4]. In
contrast, within the interfollicular epidermis, EGFR signal-
ing maintains proliferation while proliferation of follicular
keratinocytes is independent of the receptor [3, 4]. Roles for
EGFR at multiple cell cycle checkpoints would increase the
plasticity of the skin’s response to environmental insults such
as wounding or UV exposure. Because cell cycle checkpoints
provide time for DNA repair after exposure to a mutagen,
thecontrolofmultiplecellcyclecheckpointsbyEGFRunder-
scores the potential importance of the receptorin controlling
cell cycle progression in response to UV.
In response to UV-induced activation, EGFR increases
cell proliferation, suppresses cell death, and augments and
accelerates epidermal hyperplasia. In addition, EGFR in-
creases G1 cyclin expression and suppresses the expression
of the CDK inhibitor, p21waf1 (see [23] and unpublished ob-
servations). The UV-induced activation of ERK1/2, p38 ki-
nase, and JNK MAP kinases as well as PI3K/AKT is largely
dependent on EGFR [21]. EGFR’s inﬂuence on prolifera-
tion following UV exposure was mediated by its activation
of both JNK and PI3K/AKT [22, 23]. EGFR-mediated acti-
vation of MAP kinases may also increase keratinocyte sur-
vival. Together with evidence of the antiapoptotic eﬀect of
EGFR-dependent PI3K/AKT signaling in response to UV
[22, 25, 26], these data reveal the importance of multi-
ple EGFR-activated pathways in cutaneous responses to UV.
They also suggest speciﬁcity of the various EGFR-dependent
signaling pathways in diﬀerentially regulating the biological
functions of the skin. These data further suggested to us that
repeated activation of EGFR upon frequent exposure to UV
might promote skin tumor development.
4. EGFR PROMOTES UV-INDUCED SKIN
TUMORIGENESIS
TotestourhypothesisthatrepeatedactivationofEGFRupon
chronic exposure to UV contributes to UV-induced skin car-
cinogenesis, we used a genetically initiated mouse model
with enhanced susceptibility to skin tumor development.T. B. El-Abaseri and L. A. Hansen 3
This mouse is the v-rasHa transgenic Tg · AC mouse, which
rapidly develops skin tumors following UV irradiation.
Groups of Tg·AC mice were treated with the EGFR inhibitor
AG1478, a tyrphostin that blocks its kinase activity, or the
vehicle alone 2 hours prior to UV exposure. Inhibition of
the UV-induced activation of EGFR blocks the development
of about half of the tumors, with an even larger reduction
in tumor growth [21]. These results are especially striking
given the relatively brief period of receptor inhibition over
the course of the tumor experiment. The reduction in tumor
development upon inhibition of EGFR is associated with a
suppression or delay in the development of epidermal hyper-
plasia afterUVirradiation, aneﬀectobservedin UV-exposed
Egfr nullskingraftsaswell[21].EGFRincreasesUV-induced
epidermal hyperplasia by both increasing cell proliferation
and suppressing cell death [21]. These eﬀects of EGFR on
cell division and cell death further implicate EGFR in modu-
lating DNA repair and the acquisition of mutations after UV.
Whether deregulated EGFR signaling inhibits DNA damage
repair and increases mutagenesis remains to be investigated.
The suppression of UV-induced skin tumorigenesis by
inhibition of EGFR suggests that EGFR might serve as a
molecular target for chemoprevention or treatment of UV-
induced skin cancer. This strategy could prove useful in
patient populations with increased susceptibility to UV-
induced skin carcinogenesis. For example, organ transplant
recipientsonimmunosuppressivetherapyhaveextraordinar-
ily high rates of very aggressive squamous cell carcinomas as-
sociated with UV exposure. Many of these patients develop
multiple skin tumors as well. In this population, methods
for the prevention of skin cancer are much needed. How-
ever, adverse skin reactions, including skin rashes, develop
in cancer patients treated with EGFR inhibitors or mono-
clonal antibodies to the receptor [28], a response predicted
by the Egfr null mouse phenotype [4, 28]. Additional pre-
clinical and clinical studies to determine creative alternatives
todecreasetheadverseeﬀectsoftheinhibitorsforfutureclin-
ical studies targeted to the skin are clearly needed. For exam-
ple, novel topical drug delivery systems could restrain drug
delivery to the epidermis, thus eliminating the dermal side
eﬀectsoftheseinhibitors.Thesetrialsshouldalsoidentifythe
additive or synergistic eﬀect of inhibition of EGFR in combi-
nation with the inhibition of other EGFR family members.
5. SUMMARY
In summary, we have demonstrated multiple functions for
EGFR in the skin, which depend on the localization of the
cell within the skin. Upon UV-induced activation of the
receptor, EGFR increases proliferation, suppresses apopto-
sis, augments hyperplasia, and increases UV-induced skin
tumorigenesis. Taken together, these data provide insights
into the mechanisms by which EGFR enhances keratinocyte
proliferation under normal growth conditions and during
UV-induced skin tumorigenesis, as illustrated in Figure 1,
which may be important for the treatment or prevention
of skin cancer. EGFR’s regulation of the response of the
















Figure 1: Mechanisms through which the UV-induced activation
of EGFR contributes to skin carcinogenesis.
signaling prior to UV exposure may be an eﬀective means
to prevent UV-induced skin tumorigenesis. Moreover, un-
derstanding EGFR-dependent signal transduction after UV
exposure will aid in investigations of the role of EGFR in
other UV-induced skin pathologies such as sunburn and
photoaging. We propose that molecular targeting of EGFR
may be an eﬀective strategy in skin carcinogenesis treat-
ment of prevention, particularly in highly susceptible pop-
ulations such as immune-compromised organ transplant re-
cipients.
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